๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors

โœ Scribed by Hui K. Gan; Paul L. Mitchell; Peter Galettis; Ian D. Davis; Jonathan Cebon; Paul de Souza; Matthew Links


Publisher
Springer
Year
2005
Tongue
English
Weight
248 KB
Volume
58
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A phase I study of gemcitabine and docet
โœ David P. Ryan; Thomas J. Lynch; Michael L. Grossbard; Michael V. Seiden; Charles ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB ๐Ÿ‘ 2 views

A Phase I study was initiated to determine the maximum tolerated dose of weekly gemcitabine combined with monthly, fixed-dose docetaxel. ## METHODS. Patients with metastatic solid tumors were treated with docetaxel, 60 mg/m 2 , on Day 1 every 28 days. Gemcitabine was administered on Days 1, 8, and